- Home
- ARQT vs CRF Comparison
ARQT vs CRF Comparison
Compare ARQT & CRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- CRF
- Stock Information
- Founded
- ARQT 2016
- CRF 1973
- Country
- ARQT United States
- CRF United States
- Employees
- ARQT N/A
- CRF N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- CRF Finance/Investors Services
- Sector
- ARQT Health Care
- CRF Finance
- Exchange
- ARQT Nasdaq
- CRF Nasdaq
- Market Cap
- ARQT 1.1B
- CRF 926.5M
- IPO Year
- ARQT 2020
- CRF N/A
- Fundamental
- Price
- ARQT $13.08
- CRF $8.83
- Analyst Decision
- ARQT Strong Buy
- CRF
- Analyst Count
- ARQT 5
- CRF 0
- Target Price
- ARQT $17.00
- CRF N/A
- AVG Volume (30 Days)
- ARQT 2.0M
- CRF 620.5K
- Earning Date
- ARQT 02-25-2025
- CRF 01-01-0001
- Dividend Yield
- ARQT N/A
- CRF 17.97%
- EPS Growth
- ARQT N/A
- CRF N/A
- EPS
- ARQT N/A
- CRF N/A
- Revenue
- ARQT $138,708,000.00
- CRF N/A
- Revenue This Year
- ARQT $209.03
- CRF N/A
- Revenue Next Year
- ARQT $49.00
- CRF N/A
- P/E Ratio
- ARQT N/A
- CRF N/A
- Revenue Growth
- ARQT 182.84
- CRF N/A
- 52 Week Low
- ARQT $3.59
- CRF $6.05
- 52 Week High
- ARQT $16.20
- CRF $8.56
- Technical
- Relative Strength Index (RSI)
- ARQT 46.24
- CRF 52.10
- Support Level
- ARQT $12.61
- CRF $8.50
- Resistance Level
- ARQT $14.36
- CRF $9.02
- Average True Range (ATR)
- ARQT 0.98
- CRF 0.17
- MACD
- ARQT -0.32
- CRF 0.00
- Stochastic Oscillator
- ARQT 13.09
- CRF 63.46
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About CRF Cornerstone Total Return Fund Inc. (The)
Cornerstone Total Return Fund Inc is a diversified closed-end management company. Its objective is to seek capital appreciation with current income as a secondary objective. The company invests in sectors such as Information Technology; Health Care; Financials; Communication Services; Consumer Discretionary; Industrials; Exchange-Traded Funds; Utilities; Energy; Real Estate and others.